(Q34019357)

30 July 2017

title

Emerging treatments in cystic fibrosis (English)

1 reference

30 July 2017

0 references

Andrew M Jones

1

0 references

author name string

Jennifer M Helm

series ordinal

2

1 reference

30 July 2017

publication date

1 October 2009

1 reference

30 July 2017

1 reference

30 July 2017

volume

69

1 reference

30 July 2017

issue

14

1 reference

30 July 2017

page(s)

1903-1910

1 reference

Evidence on improved outcomes with early diagnosis of cystic fibrosis through neonatal screening: enough is enough!

30 July 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11318500-000000000-00000

Efficacy, safety, and local pharmacokinetics of highly concentrated nebulized tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11318500-000000000-00000

Inhaled mannitol improves lung function in cystic fibrosis.

21 January 2018

1 reference

12 December 2020

Improving rate of decline of FEV1 in young adults with cystic fibrosis

1 reference

12 December 2020

Sugar sweet and deadly?

1 reference

12 December 2020

A double-blind randomized placebo-controlled phase III study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patients

1 reference

12 December 2020

Non-viral vectors in cystic fibrosis gene therapy: recent developments and future prospects

1 reference

12 December 2020

New concepts of the pathogenesis of cystic fibrosis lung disease

1 reference

12 December 2020

A phase I trial of intranasal Moli1901 for cystic fibrosis

1 reference

12 December 2020

Safety and efficacy of recombinant alpha(1)-antitrypsin therapy in cystic fibrosis

1 reference

12 December 2020

Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial.

1 reference

12 December 2020

Computed tomography in the evaluation of cystic fibrosis lung disease

1 reference

12 December 2020

Cystic fibrosis mortality and survival in the UK: 1947-2003

1 reference

12 December 2020

Retrospective review of the effects of rhDNase in children with cystic fibrosis

1 reference

12 December 2020

Mucus clearance and lung function in cystic fibrosis with hypertonic saline

1 reference

12 December 2020

Inhaled Aztreonam Lysine for Chronic Airway Pseudomonas aeruginosa in Cystic Fibrosis

1 reference

12 December 2020

Clinical use of Ibuprofen is associated with slower FEV1 decline in children with cystic fibrosis

1 reference

12 December 2020

Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis.

1 reference

12 December 2020

Macrolide antibiotics for cystic fibrosis

1 reference

12 December 2020

Multicenter Randomized Controlled Trial of Withdrawal of Inhaled Corticosteroids in Cystic Fibrosis

1 reference

12 December 2020

A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis

1 reference

12 December 2020

Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis

1 reference

12 December 2020

Phase 2 randomized safety and efficacy trial of nebulized denufosol tetrasodium in cystic fibrosis.

1 reference

12 December 2020

Clinical trials in cystic fibrosis

1 reference

12 December 2020

A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis

1 reference

12 December 2020

Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis

1 reference

12 December 2020

Plant host and sugar alcohol induced exopolysaccharide biosynthesis in the Burkholderia cepacia complex

1 reference

12 December 2020

Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group

1 reference

12 December 2020

Inhalation of Moli1901 in patients with cystic fibrosis.

1 reference

12 December 2020

High-dose ibuprofen in cystic fibrosis: Canadian safety and effectiveness trial

1 reference

12 December 2020

Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus.

1 reference

12 December 2020

Prediction of Mortality in Patients with Cystic Fibrosis

1 reference

12 December 2020

Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial

1 reference

12 December 2020

Dornase alfa in the treatment of cystic fibrosis in Europe: A report from the Epidemiologic Registry of Cystic Fibrosis

1 reference

12 December 2020

Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group

1 reference

12 December 2020

Risk of persistent growth impairment after alternate-day prednisone treatment in children with cystic fibrosis

1 reference

12 December 2020

Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial.

1 reference

12 December 2020

Bronchial provocation testing with dry powder mannitol in children with cystic fibrosis

1 reference

12 December 2020

Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial

1 reference

12 December 2020

Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial

1 reference

12 December 2020

Early detection of cystic fibrosis lung disease: multiple-breath washout versus raised volume tests

1 reference

12 December 2020

Antibody responses induced by long-term vaccination with an octovalent conjugate Pseudomonas aeruginosa vaccine in children with cystic fibrosis

1 reference

12 December 2020

10.2165/11318500-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

30 July 2017

1033663371

0 references

1 reference